Clinical status of patients 1 year after hospital discharge following recovery from COVID-19: a prospective cohort study
Background The long-term clinical status of coronavirus disease 2019 (COVID-19) in recovered patients remains largely unknown. This prospective cohort study evaluated clinical status of COVID-19 and explored the associated risk factors. Methods At the outpatient visit, patients underwent routine blood tests, physical examinations, pulmonary function tests, 6-min walk test, high-resolution computed tomography (CT) of the chest, and extrapulmonary organ function tests. Results 230 patients were analyzed. Half (52.7%) reported at least one symptom, most commonly fatigue (20.3%) and sleep difficulties (15.8%). Anxiety (8.2%), depression (11.3%), post-traumatic symptoms (10.3%), and sleep disorders (26.3%) were also reported. Diffusion impairments were found in 35.4% of the patients. Abnormal chest CT scans were present in 63.5% of the patients, mainly reticulation and ground-glass opacities. Further, a persistent decline in kidney function was observed after discharge. SARS-CoV-2-specific antibodies of IgA, IgG, and IgM were positive in 56.4%, 96.3%, and 15.2% of patients, respectively. Multivariable logistic regression showed that disease severity, age, and sex were closely related to patient recovery. Conclusions One year after hospital discharge, patients recovered from COVID-19 continued to experience both pulmonary and extrapulmonary dysfunction. While paying attention to pulmonary manifestations of COVID-19, follow-up studies on extrapulmonary manifestations should be strengthened..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Annals of intensive care - 12(2022), 1 vom: 10. Juli |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Dapeng [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
© The Author(s) 2022 |
---|
doi: |
10.1186/s13613-022-01034-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR047547456 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR047547456 | ||
003 | DE-627 | ||
005 | 20230509103539.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220712s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13613-022-01034-4 |2 doi | |
035 | |a (DE-627)SPR047547456 | ||
035 | |a (SPR)s13613-022-01034-4-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Dapeng |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical status of patients 1 year after hospital discharge following recovery from COVID-19: a prospective cohort study |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2022 | ||
520 | |a Background The long-term clinical status of coronavirus disease 2019 (COVID-19) in recovered patients remains largely unknown. This prospective cohort study evaluated clinical status of COVID-19 and explored the associated risk factors. Methods At the outpatient visit, patients underwent routine blood tests, physical examinations, pulmonary function tests, 6-min walk test, high-resolution computed tomography (CT) of the chest, and extrapulmonary organ function tests. Results 230 patients were analyzed. Half (52.7%) reported at least one symptom, most commonly fatigue (20.3%) and sleep difficulties (15.8%). Anxiety (8.2%), depression (11.3%), post-traumatic symptoms (10.3%), and sleep disorders (26.3%) were also reported. Diffusion impairments were found in 35.4% of the patients. Abnormal chest CT scans were present in 63.5% of the patients, mainly reticulation and ground-glass opacities. Further, a persistent decline in kidney function was observed after discharge. SARS-CoV-2-specific antibodies of IgA, IgG, and IgM were positive in 56.4%, 96.3%, and 15.2% of patients, respectively. Multivariable logistic regression showed that disease severity, age, and sex were closely related to patient recovery. Conclusions One year after hospital discharge, patients recovered from COVID-19 continued to experience both pulmonary and extrapulmonary dysfunction. While paying attention to pulmonary manifestations of COVID-19, follow-up studies on extrapulmonary manifestations should be strengthened. | ||
650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
650 | 4 | |a Pulmonary dysfunction |7 (dpeaa)DE-He213 | |
650 | 4 | |a Extrapulmonary dysfunction |7 (dpeaa)DE-He213 | |
650 | 4 | |a SARS-CoV-2 antibodies |7 (dpeaa)DE-He213 | |
650 | 4 | |a Risk factor |7 (dpeaa)DE-He213 | |
700 | 1 | |a Liao, Xuejiao |4 aut | |
700 | 1 | |a Ma, Zhenghua |4 aut | |
700 | 1 | |a Zhang, Lina |4 aut | |
700 | 1 | |a Dong, Jingke |4 aut | |
700 | 1 | |a Zheng, Guoqin |4 aut | |
700 | 1 | |a Zi, Mei |4 aut | |
700 | 1 | |a Peng, Wujian |4 aut | |
700 | 1 | |a Wei, Lanlan |4 aut | |
700 | 1 | |a Li, Zhiyan |4 aut | |
700 | 1 | |a Kong, Yingjun |4 aut | |
700 | 1 | |a Wang, Lifei |4 aut | |
700 | 1 | |a Liu, Dongjing |4 aut | |
700 | 1 | |a Wang, Fang |4 aut | |
700 | 1 | |a He, Qing |4 aut | |
700 | 1 | |a Li, Guobao |4 aut | |
700 | 1 | |a Zhang, Zheng |0 (orcid)0000-0002-3544-1389 |4 aut | |
700 | 1 | |a Liu, Lei |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of intensive care |d Heidelberg : Springer, 2011 |g 12(2022), 1 vom: 10. Juli |w (DE-627)SPR031925561 |w (DE-600)2617094-2 |x 2110-5820 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2022 |g number:1 |g day:10 |g month:07 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/s13613-022-01034-4 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
951 | |a AR | ||
952 | |d 12 |j 2022 |e 1 |b 10 |c 07 |